ANI Pharmaceuticals (ANIP) P/FCF US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
P/FCF | 40.4 | -6.55 | -28.6 | -13.7 | 9.88 | 13.8 | |||
Changes by years, y/y, % | +328% | -116% | +336% | -52% | -172% | +0.9% |
ANI Pharmaceuticals. P/FCF
ANI Pharmaceuticals. P/FCF, changes, %
ANI Pharmaceuticals (ANIP) P/FCF US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
P/FCF | 20.7 | 10.4 | 13.9 | 13.1 | 13.1 | 13.8 | ||
Changes by years, y/y, % | -308% | -176% | -116% | -74% | -37% | |||
Changes by quarters, q/q, % | -58% | -50% | +33% | -6% | +1% |